Definition
Calculation
Relevant dimensions and subgroups
Preferred data type and data source
Data availability
Data periodicity
Rationale
Remarks
References
Work to do
DOCUMENTATION SHEET FOR: Indicator: 59. Cervical cancer screening SHORTLIST sub-division: D) Health interventies: health services Status: implementation section Date last modification documentation sheet: 01-09-2011 |
Definition | ![]() |
Proportion of women (aged 20-69) reporting to have undergone a cervical cancer screening test within the past three years. |
Calculation | ![]() |
Percentage of women aged 20-69 reporting to have had a cervical smear test (pap smear) within the last 3 years, derived from EHIS questions PA.13 and PA.14. PA.13: Have you ever had a cervical smear test? Yes / No; PA.14: When was the last time you had a cervical smear test? Within the past 12 months / More than 1 year, but not more than 2 years / More than 2 years, but not more than 3 years / Not within the past 3 years. EHIS data will not be age standardized. |
Relevant dimensions and subgroups | ![]() |
|
Preferred data type and data source | ![]() |
Preferred data type HIS Preferred data source Preferred source: Eurostat (EHIS = interim source, see remarks) |
Data availability | ![]() |
BE, BG, CZ, DE, EE, EL, ES, FR, IT, CY, LV, HU, MT, AT, PL, RO, SI, SK, CH, NO and TR conducted a first wave of EHIS between 2006 and 2010. It is noted that not in all of these countries a full scale survey was carried out; in some only specific modules were applied, in others the full questionnaire was applied in a small pilot sample. It is expected that all EU Member States will conduct EHIS in the second wave, which is planned for 2014. The results of the first wave are expected to be published in two stages, 11 countries in October 2010, the remaining countries in April 2011. EHIS data are available by sex, 8 age groups (15-24/25-34/35-44/45-54/55-64/65-74/75-84/85+) and ISCED groups. |
Data periodicity | ![]() |
EHIS will be conducted once every 5 years. The first wave took place in 2007/2010 (with some derogations in 2006) and the second wave is planned for 2014. |
Rationale | ![]() |
Among all malignant tumors, cervical cancer is the one that can be most effectively controlled by screening. Detection of cytological abnormalities by microscopic examination of Pap smears, and subsequent treatment of women with high-grade cytological abnormalities avoids development of cancer. Information collected in population surveys can be directly used by the public health decision makers in order to possibly adapt the organization of the prevention/screening programmes. The domain of cervical cancer screening is a priority in European Community public health policy. |
Remarks | ![]() |
|
References | ![]() |
Work to do | ![]() |
Monitor EHIS/Eurostat developments |



